13

February

Patient-Reported Outcomes: indicators for oncology drug-approvals

NCODA supports the principle that medications should improve the patient’s quality of life while simultaneously treating the disease. We will continue to follow these developments as our patient-centered approach reaches the heart of clinical trial design in the oncology space. Article here

Matthew

Matthew has blogged 60 posts